Rigel Pharmaceuticals Shows Rising Relative Strength; Still Shy Of Key Benchmark
Rigel Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength RatingThe post Rigel Pharmaceuticals Shows Rising Relative Strength; Still Shy Of Key Benchmark appeared first on Investor's Business Daily.